GLP-1 Drug Repurposing for Addiction Disorders Hampered by High Costs and Legal Hurdles Don Tracy, Associate Editor Armando Castro, partner, emerging companies, venture capital, Lowenstein Sandler, explains how regulatory, patent, and reimbursement challenges are slowing venture investment in GLP-1 and psychedelic addiction therapies
Meanwhile, ongoing clinical research and rising demand for broad, comprehensive treatment options keep pushing adoption across different regions, year after year
What This Means for Patients Using GLP-1s GLP-1 receptor agonists remain among the most effective treatments for weight loss and type 2 diabetes, and for most patients, the benefits far outweigh the risks
This pairing is particularly popular for those looking to support their immune system and skin health, as both nutrients play vital roles in collagen production and antioxidant protection
The allure of radiant skin and enhanced vitality often leads us to explore various health supplements, and glutathione has emerged as a leading contender